Traction & Milestones
18-month path from seed to Series A
Seed-to-Series A Roadmap
| Period | Team Size | Customers | ARR | Key Milestones |
|---|---|---|---|---|
| Q1 2026 (closed) | 12 | 1 | ~$8K one-time | Apexon SOW signed (March-June 2026). MVP development continued. |
| Q2 2026 (current) | 12 | 1-2 | $50K-$150K | MVP complete May 1. Apexon pilot live; design-partner pipeline in healthcare and veterinary. |
| June 2026 | Close $4.5M Seed. Engagement detail on request via the portal contact form. | |||
| M1-M3 · Q3 2026 | 14-16 | 2-3 | ~$250K | Design-partner conversion. Close 2-3 paying customers. First vertical reference in healthcare or veterinary. |
| M4-M6 · Q4 2026 | 16-19 | 4-6 | ~$960K (~$80K MRR) | Land and expand. Second workflow live in initial customers. Repeatable 2-4 week pilot-to-production cycle. |
| M7-M9 · Q1 2027 | 17-19 | 10-12 | ~$2.2M (~$180K MRR) | Operating leverage. Approach operational breakeven. Channel partners in active co-sell. Year 1 close: $2-$4M ARR (deck Slide 16). |
| M10-M18 · Q2-Q4 2027 | 18-19 | 25-40 | $6.2M-$9M | Series A ready. 25-40 customers across wedge verticals. Institutional Series A syndicate engaged (deck Slide 16). |
| Q3-Q4 2027 | Close Series A: $6.2M-$9M ARR run-rate, 25-40 customers. Round size and valuation engaged at the syndicate stage. | |||
Current State (Q1 2026)
Team
12-person team: 4 executives (CEO, CTO, SVP Business Operations, Chief Architect) + 8 developers (~$665K/yr)
Product Development
Multikor MVP deployed and operational. Active SOW with Apexon (March-June 2026)
Sales Pipeline
Target prospect list of 200 qualified companies
Funding Status
$4.5M seed round in progress. Engagement and round detail on request via the portal contact form.
Infrastructure & Partnership
AWS-native cloud plus proven on-prem hybrid on NVIDIA GB10 (Bifrost). AWS Inception partner; startup credits accelerate Y1 GM (balance under NDA).
Financial Projections
Deck Slide 16 ramp through Year 3, then illustrative post-Series-B trajectory.
Revenue Trajectory (Direct + Channel)
| Year | Direct ARR | Channel ARR | Total ARR | Customers (cumulative) |
|---|---|---|---|---|
| Deck Slide 16 horizon | ||||
| Year 1 · 2026 | $1.5M-$3.4M | $480K-$600K | $2M-$4M | 10-12 (1 channel) |
| Year 2 · 2027 (Series A ready) | $3.7M-$5.4M | $2.5M-$3.6M | $6.2M-$9M | 25-40 (3-5 channel) |
| Year 3 · 2028 (Series B horizon) | $17M-$25M | $8M-$25M | $25M-$50M | 75-100+ (5-10 channel) |
| Illustrative post-Series-B (beyond deck horizon) | ||||
| 2029 | $40M-$60M | $15M-$25M | $55M-$85M | 10-15 channel |
| 2030 | $80M-$120M | $50M-$80M | $130M-$200M | 20-30 channel |
| 2031 | $130M-$200M | $170M-$250M | $300M-$450M | 30-45 channel |
Years 1-3 align to deck Slide 16 (Path to Series A) and deck Slide 13 ICP bands (SMB $50-80K Y1, Mid-market $200-500K Y1, Channel $480-600K Y1 → $1.2M+ Y3). Years 4-6 are illustrative projections beyond the deck horizon; multiples reflect channel-led compounding through Series B.
For detailed unit economics (LTV:CAC, margins, NRR), see Business Model →
Capital Efficiency
$500K built a deployed platform, a 12-person team, and an active customer SOW — with $300K still in the bank.
What $500K Built (Pre-Seed → Today)
What $4.5M Seed Delivers (18-Month Horizon, deck Slide 16)
18-month post-seed trajectory: MRR vs. expenses, cash position ($K)
Cash bottoms at ~$3.09M (M15) with 38% of seed deployed; the remaining ~$3.3M funds the Series A bridge. This is the deck Slide 17 'Series A from strength, not survival' framing made explicit — Multikor is not capital-constrained at Series A and round size is set by growth plan, not runway.
Chart Assumptions
Investment Opportunity
Seed round in progress. Engagement detail on request via the portal contact form.
Apexon design-partner pilot live (5,500+ engineer BPO, Goldman Sachs-backed). Healthcare and veterinary design partners onboarding. Round terms and detail on request.
Use of Seed Funds
Aligned to deck Slide 17.
Hardened SLM stack, prompt lifecycle, self-healing pipeline at production scale.
Operator-focused AEs, channel partner enablement, vertical playbooks.
Healthcare, veterinary, channel-led onboarding and retention.
HIPAA, SOC 2, audit posture, finance/ops infrastructure.
AWS partnership credits offset Year 1 infra
AWS startup credits reduce effective infrastructure costs for early customer onboarding and accelerate Year 1 gross margin. Credit balance and dates available under NDA.
Success Criteria for Series A (Q3-Q4 2027, deck Slide 16)
Projected Returns
Illustrative · beyond deck horizon
Deck Slides 13 and 16 ground the model through Year 3 ($25-$50M ARR, 2028). The projections below extend that ramp through Series B and into exit using channel-led compounding. All numbers past 2028 are illustrative.
Valuation milestones (2026 seed → 2031 exit) with implied seed return at each stage
Methodology: Series A milestone scaled from deck Slide 16 ARR target ($6.2-$9M). Out-year exit valuations assume an ~8× revenue multiple (consistent with mature AI-platform comparables) and dilution-adjusted ownership (~8-9% after Series A/B). Linear scale chosen to preserve the visual magnitude of value creation. Round terms and ownership detail on request.
| Scenario | Timeline | ARR | Valuation (8× rev) | Seed Return |
|---|---|---|---|---|
| Conservative | 2030 (4-5 years) | $130M-$200M | $1.0B-$1.6B | 14-22× |
| Upside | 2031 (5-6 years) | $300M-$450M | $2.4B-$3.6B | 40-55× |
Returns assume ~8× revenue multiple and post-dilution ownership of ~8-9% after Series A/B. Specific round terms and dilution math on request.